Duke Health

Skip to main content

HIV

A Trial HIV Vaccine Triggered Elusive and Essential Antibodies in Humans
A Trial HIV Vaccine Triggered Elusive and Essential Antibodies in Humans
|
  • Research
  • HIV
GPS-like System Shows Promise as HIV Vaccine Strategy to Elicit Critical Antibodies
GPS-like System Shows Promise as HIV Vaccine Strategy to Elicit Critical Antibodies
|
  • Research
  • HIV
Scientists See an Ultra-Fast Movement in an HIV-1 Surface Protein
Scientists See an Ultra-Fast Movement in an HIV-1 Surface Protein
|
  • Research
  • HIV
HIV Vaccine Takes Step Forward with Confirmation of Neutralizing Antibodies
HIV Vaccine Takes Step Forward with Confirmation of Neutralizing Antibodies
|
  • Research
  • HIV
  • Infectious Disease
Study Identifies How Stealthy HIV Evades Drugs and Immunity
Study Identifies How Stealthy HIV Evades Drugs and Immunity
|
  • Research
  • HIV
Federal Grant to Duke University School of Medicine Expands HIV Research
Federal Grant to Duke University School of Medicine Expands HIV Research
|
  • Grants/Awards
  • HIV
  • Infectious Disease
Potential HIV Vaccine Component Proves Effective in Primate Study
Potential HIV Vaccine Component Proves Effective in Primate Study
|
  • Research
  • HIV
Duke Awarded Federal Grant to Build Structural Models of HIV
Duke Awarded Federal Grant to Build Structural Models of HIV
|
  • Grants/Awards
  • HIV
Study Shows mRNA Vaccine Technology Can Be Used For HIV Vaccines
Study Shows mRNA Vaccine Technology Can Be Used For HIV Vaccines
|
  • Research
  • HIV
  • Infectious Disease
Duke Institute Lands Federal Contract to Make Vaccine Candidates
Duke Institute Lands Federal Contract to Make Vaccine Candidates
|
  • Grants/Awards
  • Research
  • HIV
  • Infectious Disease
Newly Identified Antibody Can Be Targeted by HIV Vaccines
Newly Identified Antibody Can Be Targeted by HIV Vaccines
|
  • Research
  • HIV
  • Infectious Disease
Immune System Can be Coaxed into Selecting Key Antibodies to Fight HIV
Immune System Can be Coaxed into Selecting Key Antibodies to Fight HIV
|
  • Research
  • HIV
Duke Human Vaccine Institute Receives Virology Quality Assurance Program Contract
Duke Human Vaccine Institute Receives Virology Quality Assurance Program Contract
|
  • Grants/Awards
  • HIV
Duke Institute Awarded $129 Million Grant in Ongoing Quest for HIV Vaccine
Duke Institute Awarded $129 Million Grant in Ongoing Quest for HIV Vaccine
|
  • Grants/Awards
  • HIV
New Insight on Potent HIV Antibody Could Improve Vaccine Design
New Insight on Potent HIV Antibody Could Improve Vaccine Design
|
  • Research
  • HIV
A Look Back at 2018
A Look Back at 2018
|
  • Clinical Care
  • Grants/Awards
  • Health System
  • Research
  • Cancer
  • Children's Health
  • Health Technology
  • HIV
  • Quality and Safety
  • Surgery
  • Transplant
Roadmap Reveals Shortcut to Recreate Key HIV Antibody for Vaccines
Roadmap Reveals Shortcut to Recreate Key HIV Antibody for Vaccines
|
  • Research
  • HIV
Researchers Find How Natural Killer Cells Regulate Protective HIV Antibodies
Researchers Find How Natural Killer Cells Regulate Protective HIV Antibodies
|
  • Research
  • HIV
Viewpoint: Why is the Study of the Immune System So Important?
Viewpoint: Why is the Study of the Immune System So Important?
|
  • Education
  • HIV
  • Infectious Disease
  • Inflammatory and Immune Disorders
Researchers Map How HIV Escapes Mother’s Immune Attack to Infect Infants
Researchers Map How HIV Escapes Mother’s Immune Attack to Infect Infants
|
  • Research
  • HIV
Duke-Led Team Develops More Accurate Tool to Track New HIV Infections
Duke-Led Team Develops More Accurate Tool to Track New HIV Infections
|
  • Research
  • HIV
Viewpoint: What did it take to change HIV from a fatal diagnosis?
Viewpoint: What did it take to change HIV from a fatal diagnosis?
|
  • Education
  • HIV
Duke Human Vaccine Institute Receives Contract Renewal for Lab Oversight
Duke Human Vaccine Institute Receives Contract Renewal for Lab Oversight
|
  • Grants/Awards
  • HIV
Investigational Vaccine Protected Monkeys from HIV-Like Virus
Investigational Vaccine Protected Monkeys from HIV-Like Virus
|
  • Research
  • HIV
Researchers Map Pathways to Protective Antibodies for an HIV Vaccine
Researchers Map Pathways to Protective Antibodies for an HIV Vaccine
|
  • Research
  • HIV
Subscribe to HIV